PRURIGO NODULARIS (PN)
Clinical trials for PRURIGO NODULARIS (PN) explained in plain language.
Never miss a new study
Get alerted when new PRURIGO NODULARIS (PN) trials appear
Sign up with your email to follow new studies for PRURIGO NODULARIS (PN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study reveals how dupilumab fights itchy skin disease
Disease control Recruiting nowThis study follows 40 adults with moderate-to-severe prurigo nodularis who are starting dupilumab, a targeted therapy. Researchers will track how well the drug reduces itching and skin lesions over time, and also study changes in the immune system and skin tissue. The goal is to …
Matched conditions: PRURIGO NODULARIS (PN)
Sponsor: UMC Utrecht • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New pill could stop the maddening itch of prurigo nodularis
Symptom relief Recruiting nowThis study tests an experimental drug called ICP-332 for people with prurigo nodularis, a skin condition causing many intensely itchy bumps. The trial will include 135 adults and compare the drug against a placebo to see if it safely reduces itch severity over 16 weeks. Participa…
Matched conditions: PRURIGO NODULARIS (PN)
Phase: PHASE2 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Symptom relief
Last updated May 26, 2026 07:43 UTC